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Abstract
Background: Endoscopic band ligation (EBL) is generally accepted as the treatment of choice for bleeding from
esophageal varices. It is also used for secondary prophylaxis of esophageal variceal hemorrhage. However, there is
no data or guidelines concerning endoscopic control of ligation ulcers. We conducted a retrospective study of EBL
procedures analyzing bleeding complications after EBL.
Methods: We retrospectively analyzed data from patients who underwent EBL. We analyzed several data points,
including indication for the procedure, bleeding events and the time interval between EBL and bleeding.
Results: 255 patients and 387 ligation sessions were included in the analysis. We observed an overall bleeding rate
after EBL of 7.8%. Bleeding events after elective treatment (3.9%) were significantly lower than those after
treatment for acute variceal hemorrhage (12.1%). The number of bleeding events from ligation ulcers and variceal
rebleeding was 14 and 15, respectively. The bleeding rate from the ligation site in the group who underwent
emergency ligation was 7.1% and 0.5% in the group who underwent elective ligation. Incidence of variceal
rebleeding did not vary significantly. Seventy-five percent of all bleeding episodes after elective treatment occurred
within four days after EBL. 20/22 of bleeding events after emergency ligation occured within 11 days after
treatment. Elective EBL has a lower risk of bleeding from treatment-induced ulceration than emergency ligation.
Conclusions: Patients who underwent EBL for treatment of acute variceal bleeding should be kept under medical
surveillance for 11 days. After elective EBL, it may be reasonable to restrict the period of surveillance to four days
or even perform the procedure in an out-patient setting.
Background
Portal hypertension is a hemostatic disorder that is often
caused by liver cirrhosis. It is defined as an increase in
blood pressure in the portal venous system. Portal
hypertension can be the origin of severe complications
in cirrhosis. Gastroesophageal varices are a potentially
life-threatening complication of portal hypertension.
Even though the outcome of bleeding from gastroeso-
phageal varices has improved, it is still associated with a
high mortality rate. The mortality rate of acute variceal
bleeding has decreased from 42% in 1981 to about 15%
to 20% at present [1-4].
Risk factors for bleeding from esophageal varices have
been identified in several randomized controlled trials
(RCT). Poor Child-Pugh score [3,5-7], bacterial infection
[6-8], elevated aspartate amino transferase levels [3], and
a hepatic venous pressure gradient greater than 20
mmHg, measured shortly after admission [5,6,8-10], are
associated with a higher bleeding rate.
Management of acute variceal bleeding consists of
pharmacologic and endoscopic treatment. Endoscopic
techniques currently used to stop variceal bleeding are
endoscopic sclerotherapy, variceal obturation with glue
and endoscopic band ligation (EBL). EBL is the endo-
scopic treatment of choice because it is an effective
treatment for bleeding from esophageal varices. It is
generally accepted and recommended for the treatment
of acute bleeding events. EBL is also used for the sec-
ondary prophylaxis of esophageal variceal hemorrhage
[11-15].
Non-selective beta-blockers are the treatment of
choice to prevent initial bleeding episodes. However,
beta-blockers do not prevent formation of esophageal
varices. For primary prophylaxis of esophageal bleeding, * Correspondence: albrecht.hoffmeister@medizin.uni-leipzig.de
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tions or intolerance to beta-blockers [14,16-19].
EBL sessions are usually repeated at 1-2 week intervals
until complete obliteration of all esophageal varices has
been achieved [15]. Complete obliteration is achieved in
about 90% of patients after 2-4 sessions. Variceal recur-
rence occurs frequently, with 20%-75% of patients
requiring repeated EBL sessions.
There is numerous data, including randomized con-
trolled trials and meta-analyses, concerning the safety
of EBL and its clinical effectiveness in controlling vari-
ceal bleeding. However, there are only few studies that
have evaluated the risk of bleeding from ligation-
induced ulcers. The results of these few studies are
contradictory [19-21]. Stiegmann et al. [21] reported
an overall complication rate of only 2%. Schepke et al.
[19] completed a multicenter trial comparing EBL with
beta-blocker therapy for primary prophylaxis of vari-
ceal bleeding. This study found the incidence of bleed-
ing from ligation ulcers after EBL to be 6.7%. Another
retrospective data analysis of EBL described hemor-
rhage from ligation ulcers as 5.7%, irrespective of the
indication [20].
Meetings were held to discuss clinical trials and pro-
pose guidelines for the management of patients with
esophageal varices. During the proceedings at the
Baveno IV workshop in April 2005, attendees came to
an agreement about the management of endoscopic
treatment of esophageal varices [14]. However, as far
as we know, there is no data or guidelines concerning
endoscopic control of ligation ulcers. Furthermore,
there is no data or guidelines on whether EBL should
be restricted to in-patients. Most gastroenterologists,
at least in Germany, do not perform out-patient EBL.
Patients are kept under surveillance until all ligation
b a n d sa r ed r o p p e do f f .T h i sm o n i t o r i n gi sb a s e do n
the theory that the process of dropping off ligation
bands is associated with an elevated risk of recurrent
bleeding.
EBL is routinely used in nearly all gastrointestinal
endoscopy units. Tremendous efforts are invested in the
therapy of esophageal varices. Despite this, there is no
evidence how to monitor patients after EBL. Gastroen-
terologists, like all other physicians, are increasingly
under economic pressure. German health insurance
funds and hospital administration executives try con-
tinuously to further minimize the duration of hospitali-
zations. We therefore conducted a retrospective study of
endoscopic band ligation procedures with regard to the
primary outcome of bleeding complications after EBL.
Furthermore we wanted to evaluate whether ligation
ulcers after EBL are a locus of high risk for procedure
associated bleeding events.
Methods
Patient characteristics
Our retrospective analysis included all patients who
underwent endoscopic band ligation of esophageal
varices between July 1, 2000 and January 31, 2007 at
our institution. A total of 291 patients with esophageal
varices have been treated. In these patients, 430 ligature
procedures have been performed. For patient character-
istics, see figure 1.
Endoscopic and hospital records were reviewed to
obtain demographic, clinical, endoscopic and follow-up
data. Data for the analysis included indication for endo-
scopic procedure, bleeding events, time interval between
EBL and bleeding, and time interval between endoscopic
procedure and dropping off of ligation bands.
Acute bleeding events from varices were defined as
active variceal bleeding (visible oozing or spurting of
blood from a varix) or the presence of stigmata of
recent bleeding in the presence of varices of grade two
or higher. Stigmata of recent hemorrhage was defined as
t h ep r e s e n c eo fa na d h e r e n tc l o t ,w h i t ep r o t r u s i o n ,
varices and blood in the stomach, or large varices in the
setting of a patient with hematemesis and no other
cause of upper gastrointestinal bleeding.
All patients were hospitalized until drop-off of all liga-
tion bands, proven by endoscopy. Patients were divided
into two subgroups according to their indication for
endoscopic treatment. The first subgroup consisted of
patients who underwent banding ligation because of an
Figure 1 Patients included in the data analysis.F r o mt h e2 9 1
patients who underwent EBL during the observation period, 255
could be enrolled in the study.
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ond subgroup included patients who underwent elective
primary or secondary treatment for prevention of bleed-
ing. Bleeding was defined as the following: (1) a bleeding
event after initial control of variceal bleeding, (2) a
bleeding event after successful EBL of non-bleeding
varices before all ligation bands dropped off. Any patient
with clinical symptoms of bleeding (i.e., new hematem-
esis, melena, tachycardia, hypotension, or insufficient
increase in hemoglobin after erythrocyte substitution)
was admitted for a new endoscopic procedure. The
cause of every incident of gastrointestinal bleeding was
evaluated by endoscopy. The diagnosis of bleeding from
the varices or from ligation ulcers was accepted if active
bleeding was identified, a clot was seen adherent to a
ligation site, or blood was detected in the upper GI-tract
and no other cause of bleeding from the gastrointestinal
tract was evident.
Endoscopic variceal ligation and further interventions
Upper gastrointestinal endoscopy and esophageal vari-
ceal band ligation was performed in all patients using a
high-resolution video endoscope (Olympus, Hamburg,
Germany) loaded with a Multiband ligator (Wilson-
Cook Medical). Only experienced endoscopists per-
formed the ligations. All endoscopists had received
training of at least one year. After training, these endos-
copists were only allowed to independently treat varices
after they had performed a minimum of ten EBL proce-
dures under surveillance of more experienced endosco-
pists. Ligation was applied beginning one centimeter
above the gastroesophageal junction. Each varix was
ligated until the bleeding stopped, the varices were era-
dicated, or the varices were reduced to grade 1. Further
sessions of treatment followed in cases of recurring or
persisting varices.
Data analysis
Statistical analysis was performed using the SPSS soft-
ware package (SPSS Inc., Chicago IL). Basic descriptive
statistics (means, standard deviations, ranges, medians,
and percentages) were used to characterize the patient’s
cohort. Variceal bleeding incidence after endoscopic
ligation was evaluated with contingency tables, including
c
2 statistics, Fisher’s exact test and Mann-Whitney-U-
Test. The Kaplan-Meier method was used to estimate
the rates of survival without bleeding. The log-rank test
w a su s e dt ot e s tt h es i g n i f i c a n c eb e t w e e nt h et w oa r m s .
A two tailed p-value less than 0.05 was considered sig-
nificant in the assessment of modus of ligation, bleeding
from ligation-sites, and associations between hemor-
rhage and other recorded factors. Kaplan-Meier estima-
tions were completed to analyze the time until new
bleeding episode. This analysis was done separately for
the groups with recurrent variceal hemorrhage and
those with bleeding from their ligation site.
All data were managed anonymised. The local ethics
committee confirmed that no ethical approval was
needed for this study.
Results
A total of 255 patients with an average age of 57.3 ±
12.6 years were included in the analysis. We performed
218 sessions of EBL to control acute hemorrhage and
212 for primary (31 sessions) or secondary (181 ses-
sions) prevention. Two patients were excluded from
analysis because their follow-up data was not available
due to referral to other hospitals. Additionally, two
other patients were excluded because acute variceal
bleeding could not be treated sufficiently by EBL.
Thirty-two patients died from procedure-independent
causes other than esophageal bleeding (Table 1) before
all ligation bands were dropped off. The remaining 255
patients underwent 387 ligation sessions. During the
follow-up period, 30 patients of this cohort had a
bleeding event related to ligation ulcers or recurrent
esophageal varices. Basic characteristics of these
patients are shown in Table 2. The number of bleeding
events from ligation ulcers and from recurrent varices
was 14 and 15, respectively. In one case, it was not
possible to retrospectively evaluate the exact source of
bleeding from the endoscopic records. All together,
patients underwent 387 ligation sessions, with 205
(53%) of these interventions performed electively for
primary (31 interventions) or secondary (174 interven-
tions) prevention of bleeding. The remaining 182
(47%) ligation sessions were carried out to control
acute bleeding events.
The analysis of bleeding events after esophageal liga-
tion was based on the location of bleeding, the indica-
tion for EBL (Table 3.) and the number of applied
ligation bands per session (Tables 4, 5). The mean time
interval between EBL and first endoscopy to control
dropping off of rubber bands was 7.4 (± 3.0) days for
patients who underwent elective EBL and 6.6 (± 3.5)
days for patients after emergency procedure.
We observed a significant difference in bleeding events
when EBL for treatment of acute variceal bleeding was
compared to electively performed ligations. The inci-
dence of hemorrhage after acute intervention was 12.1%
(22/182) compared to 3.9% (8/205) after elective treat-
ment (p = 0.004). The bleeding rate from ligation sites
in the group that underwent emergency ligation was
7.1% (13/182). This was more than fourteen times
higher than the group that underwent elective ligation
treatment (0.5% (1/205); p < 0.001). However, bleeding
incidence from recurrent varices did not vary signifi-
cantly. Bleeding from recurrent varices occurred in
seven patients (3.4%) in the elective group and in eight
patients (4.4%) in the emergency group.
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sion is shown in Tables 4 and 5. Significantly more liga-
tion bands were applied in interventions that were
followed by hemorrhage from ligation ulcers (p =
0.009). We found no significant difference in the num-
ber of bands applied when we compared those with
bleeding from recurrent varices and those who had no
bleeding at all.
An analysis of the time until bleeding in all patients
showed a predominance of bleeding events during the
first four days after endoscopic treatment (figure 2).
Sixty-seven percent of bleeding events occurred in this
period of time. The majority of these events were
hemorrhage from recurrent varices. There were eight
events from ligation sites and eleven events from recur-
rent varices. In addition, there was one hemorrhage
without clear determination of localization. Seventy-five
percent (6/8) of all bleeding episodes after elective treat-
ment occurred during the first four days after EBL treat-
ment. Most rebleedings after emergency ligation were
also observed within the first 4 days, i.e. sixty-four per-
cent (14/22) (figure 3). The latest report of a bleeding
after elective ligation treatment was on the 11th day of
the follow-up period.
Irrespective of the indication for EBL or the localiza-
tion of bleeding, the cumulative risk of bleeding events
was 7.8%. The initial bleeding risk of 2.6% in the first
four days after the endoscopic procedure was reduced
to 0.5% after 11 days (figure 4). The cumulative rebleed-
ing risk within the first four days after emergency
ligation is 0.077. After electively performed treatment,
the cumulative bleeding risk is 0.029. A comparison
using the Mann-Whitney-Test determined this differ-
ence to be significant (p = 0.04) (figure 5).
Discussion
Endoscopic band ligation (EBL) is the gold standard for
the treatment of acute bleeding of esophageal varices. It
is also effective in secondary prophylaxes and in primary
prophylaxis for patients who are insensitive to beta-
blocking agents. EBL is mostly performed in the in-
patient setting. Patients are often hospitalized until
endoscopy proves all applied ligation bands have
dropped off. However, there is no proven, scientific
rational for this strategy.
This single center, retrospective analysis studied 255
patients who underwent endoscopic ligation therapy.
The aim of this study was to propose an algorithm for
the surveillance of patients after EBL. We documented
an overall bleeding rate after EBL of 7.8%. Since this
rate is consistent with those reported in other studies
(9% to 19%) [22-28], it emphasizes that our results are
comparable with those of others. These studies were
performed for primary prophylaxes [22,23,25,26,28], sec-
ondary prophylaxes [24] and control of acute [27] vari-
ceal bleeding. The results should be therefore
comparable with results obtained in our collective.
One important result of this study was that elective
ligation therapy had a significantly lower incidence of
procedure related bleeding events than treatment of
Table 1 Death from procedure-independent causes other than esophageal bleeding (n = 32).
Death of septicaemia: 9
Death of haemorrhagic shock by intrabdominal bleeding (bleeding from intestinal tumor, intraabdominal vessels in liver hilus and omentum
majus):
3
Death of haemorrhagic shock by gastric or duodenal bleeding: 4
Death of liver failure, hepatorenal syndrom and liver malignoma (HCC: 3, metastases of colon carcinoma: 1, by haemangioendothelioma: 1) 12
Death of acute renal failure due to plasmocytoma 1
Death of pulmonary oedema due to malignant infiltration: 1
Death of cerebral oedema due to brain haemorrhage: 1
Death of ventricular fibrillation: 1
Table 2 Clinical characteristics of patients undergoing endoscopic band ligation (n = 255).
Without bleeding
complications (n = 225)
Bleeding from recurrent
varices (n = 15)
Bleeding from EBL-
ulcers (n = 14)
Bleeding from an
unknown location
(n = 1)
Age (y): 57.3 ± 12.6 53.5 ± 12.2 51.1 ± 10.4 36 ± 0.0
Sex (M/F): 146/79 9/6 10/4 0/1
Variceal strands: 3.00 ± 1.1 3.5 ± 0.6 3.1 ± 1.1 4.0 ± 0.0
Ligation sessions: 1.4 ± 0.8 2.2 ± 1.1 2.5 ± 1.6 3.0 ± 0.0
Average number of applied rubber
bands per patient and session:
6.0 ± 2.5 6.0 ± 3.0 6.4 ± 1.4 6.0 ± 0. 0
Duration of hospital stay after ligation
(days)
13.2 ± 9.1 19.0 ± 14.0 21.8 ± 15.4 18 ± 0.0
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there are no other studies relating the bleeding rate
after EBL to its indication.
When ligation bands are dropping off, ligation ulcers
may form. This process is thought to be associated with
an elevated risk of bleeding complications. For this rea-
son, patients are often hospitalized until all applied liga-
t i o nb a n d sd r o po f f .W ef o u n dt h a tb l e e d i n gf r o mE B L
induced ulcers occurred only in 3.6% (14/387) of liga-
tion sessions. In a meta-analysis comparing EBL with
sclerotherapy, Laine et al. [29] reported on bleeding
from treatment-induced ulcers in seven studies. These
studies had patient populations smaller than ours, and
ranged from n = 8 to n = 64 for EBL groups. Overall,
the documented bleeding rate from treatment-induced
ulcers after EBL in these studies was 3.3% (9/274). In
later published studies, this value has been reported as
5.4% to 14.2% in patients who underwent the procedure
for control of acute variceal hemorrhage [30-32].
These results are consistent with our study. However,
to our knowledge, there is no data correlating the indi-
cation for EBL to the bleeding rate of ligation ulcers. In
our patients, bleeding from ligation ulcers occurred in
7.1% (13/182) of cases after emergency ligation. After
electively performed EBL, bleeding at ligation ulcers
occurred only in 0.5% (1/205) of cases. Regarding our
entire patient cohort, the incidence of bleeding from
ligation-induced ulcers was 3.6% (14/387). This was
slightly lower than the bleeding rate from recurrent
varices, which was 3.9% (15/387). These findings
demonstrate that bleeding from ligation ulcers after EBL
is not the most important risk factor for bleeding. These
data also show that there is a significant difference in
bleeding incidence between ligation-induced ulcers after
electively performed ligation and after EBL for treatment
of acute hemorrhage.
Our results are supported by data concerning bleed-
ing events in recurrent varices. The overall incidence
of 3.9% (15/387) in our study is lower than data
reported by others (11.9% to 28.6%) [29-32]. However,
these studies were designed to compare different endo-
scopic techniques for the treatment of acute hemor-
rhage of esophageal varices. Therefore, they did not
consider electively performed EBL. Clinical trials have
been performed to analyze the prophylactic potential
of endoscopic band ligation in elective interventions.
In these studies, the incidence of hemorrhage from
recurrent varices ranged from 12.5% to 31.7%. Bleeding
from ligation-induced ulcers varied from 2.4% to 6.7%
[19,26,33]. This data originates from various studies
with different indications for EBL. Therefore, the stu-
dies are difficult to compare. Studies often do not
report the different sources of bleeding in their
patients. The need for data concerning EBL in all indi-
cations is important for everyday care. Our study is
the first analysis of bleeding risk from treatment-
induced ulcers or recurrent varices after EBL that
focuses on the indication for the interventions.
We were able to show a correlation between the num-
ber of applied ligation bands and the bleeding events
from ligation ulcers. In most trials, the total number of
applied bands per patient seems to have no correlation
with bleeding events. Harewood et al. compared the
number of bands per session and the bleeding incidence
[24]. In this small collection of 40 patients, no signifi-
cant correlation between the median number of bands
used in EBL sessions and bleeding episodes was found.
In our study, patients with bleeding events at ligation
sites have been treated with significantly more ligation
bands. Therefore, one can assume that application of a
higher number of ligation bands to treat esophageal
varices is a risk factor for bleeding events. Different
Table 3 Mode of ligation and source of bleeding in performed ligation sessions.
Elective ligation
(n = 205)
Ligation for acute
bleeding control
(n = 182)
p
Bleedings 8 (3.9%) 22 (12.1%) 0.004
Bleeding at ligation site 1 (0.5%) 13 (7.1%) < 0.001
Bleeding at recurrent varices 7 (3.4%) 8 (4.4%) NS
Esophageal bleeding of unknown location 0 1 (0.6%) NS
Table 4 Time intervals and applied ligation bands.
Elective ligation Ligations for acute
bleeding control
Duration of hospital stay after ligation (days) 12,4 ± 8,4 15.1 ± 10.9
Time interval between ligation and next endoscopy (days) 7.4 ± 3.0 6.6 ± 3.5
Time interval to detected band drop-off (days) 9.3 ± 4.8 9.2 ± 4.8
Avarage number of applied rubber bands per patient and sessions 6.1 ± 2.7 6.1 ± 2.7
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esophageal varices on portal venous pressure [34-36].
The results are not very consistent. However, Ramirez
and coworkers showed in a prospective study that there
is no better outcome for patients when more than six
bands are applied compared to patients treated with a
maximum of six ligation bands [37].
W ea r ea w a r et h a to u rs t u d yi so n l yar e t r o s p e c t i v e
data analysis and prospective studies should be con-
ducted in order to evaluate policy on EBL procedures.
Ligation procedures enrolled in this study could be con-
sidered as a further limitation. We reported the analysis
of all ligation sessions performed during the study per-
iod, because the aim of our study was the evaluation of
the procedure associated risk of bleeding after EBL. One
could raise concern about this evaluation because there
are patients who underwent more then one EBL proce-
dure and were included more than once in data analysis.
We therefore recalculated all data after exclusion of all
patients who underwent more than one EBL procedures
Table 5 Number of applied ligation bands per session.
Average of applied ligation bands p
Sessions without complications (n = 357): 6.0 ± 2.6
Bleeding complications altogether (n = 30): 6.8 ± 3.1 NS
Bleeding at ligation site (n = 14): 7.9 ± 2.7 0.009
Bleeding at recurrent varices (n = 15): 5.7 ± 3.7 NS
Esophageal bleeding of unknown location: 9 ± 0 NS
Figure 2 Distribution of bleeding events. All documented bleeding events after EBL (n = 30) occurred within 44 days after EBL. 15 bleeding
events were observed from recurrent varices and 14 at ligation sites. In one case, the location of bleeding could not be evaluated.
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bleeding and after elective EBL.
Figure 4 Kaplan-Meier estimation of cumulative survival without hemorrhage. The overall risk of bleeding after EBL is reduced from 7.8%
to 2.6% after four days, and to 0.5% after 11 days.
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sion. The reported results remained significant. (See
“Additional file 1“, for graphs see “Additional file 2“ and
“Additional file 3“)
Conclusion
Our study confirms former reports that have demon-
strated the safety and effectiveness of endoscopic band
ligation for treatment of esophageal varices. The risk of
bleeding from treatment-induced ulceration is lower
after elective EBL than after emergency intervention.
We, therefore, propose that endoscopists may consider
elective EBL as an out-patient procedure. In cases when
EBL is performed as an in-patient procedure, one may
consider restricting the period of surveillance after elec-
tive EBL to four days. Elective EBL should be done until
all varices are eradicated. An excessive application of
ligation bands should be avoided. However, we propose
to keep patients who have undergone endoscopic band
ligation due to acute esophageal hemorrhage under
medical surveillance for at least 8-11 days.
Additional file 1: Data analysis after of the first EBL procedure of all
patients. All patients who underwent more than one EBL procedures
were excluded from re-entry into data analysis after first ligation session
and data were analyzed regarding only the first EBL procedure of each
patient.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-230X-10-5-
S1.DOC]
Additional file 2: Kaplan-Meier estimation of cumulative survival
without hemorrhage regarding only the first EBL procedure per
patient. All patients who underwent more than one EBL procedures
were excluded from re-entry into data analysis after first ligation session
and Kaplan-Meier estimates were evaluated regarding only the first EBL
procedure of each patient. The overall risk of rebleeding after EBL is
reduced from 11.8% to 3.9% after four days, and to 0.8% after 11 days.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-230X-10-5-
S2.JPEG]
Figure 5 Kaplan-Meier estimation of cumulative survival without hemorrhage for elective and emergency EBL. The bleeding risk four
days after emergency EBL is significantly higher than after elective treatment, p = 0.04.
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Page 8 of 10Additional file 3: Kaplan-Meier estimation of cumulative survival
without hemorrhage for elective and emergency EBL regarding
only the first EBL procedure per patient. All patients who underwent
more than one EBL procedures were excluded from re-entry into data
analysis after first ligation session and Kaplan-Meier estimates were
evaluated regarding only the first EBL procedure of each patient. The
bleeding risk four days after emergency EBL is significantly higher than
after elective treatment, p = 0.042.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-230X-10-5-
S3.JPEG]
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